Cited by

• Endemic goiter and endemic thyroid disorders.

  Gaitan E, Nelson NC, Poole GV. Gaitan E, et al. World J Surg. 1991 Mar-Apr;15(2):205-15. doi: 10.1007/BF01659054. World J Surg. 1991. PMID: 2031356 Review.
• Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis.

  Lau LW, Ghaznavi S, Frolkis AD, Stephenson A, Robertson HL, Rabi DM, Paschke R. Lau LW, et al. Thyroid Res. 2021 Feb 25;14(1):3. doi: 10.1186/s13044-021-00094-1. Thyroid Res. 2021. PMID: 33632297 Free PMC article.
• Prevalence and Related Factors of Thyroid Nodules in Physical Examination Population in a Level-A Hospital in Jinan.

  Meng C, Yang P, Wang Y, Liu S, Wu X, Wang S. Meng C, et al. J Multidiscip Healthc. 2024 Aug 2;17:3753-3762. doi: 10.2147/JMDH.S443884. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39108774 Free PMC article.
• High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism.

  Armanini D, Nacamulli D, Scaroni C, Lumachi F, Selice R, Fiore C, Favia G, Mantero F. Armanini D, et al. Endocrine. 2003 Nov;22(2):155-60. doi: 10.1385/ENDO:22:2:155. Endocrine. 2003. PMID: 14665720
• Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration.

  Foppiani L, Tancredi M, Ansaldo GL, Ceppa P, Auriati L, Torre GC, Minuto F, Giusti M. Foppiani L, et al. J Endocrinol Invest. 2003 Jan;26(1):29-34. doi: 10.1007/BF03345119. J Endocrinol Invest. 2003. PMID: 12602531